Literature DB >> 21710140

Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons.

Régis Azizieh1, David Orduz, Patrick Van Bogaert, Tristan Bouschet, Wendy Rodriguez, Serge N Schiffmann, Isabelle Pirson, Marc J Abramowicz.   

Abstract

The potassium channel tetramerization domain-containing protein 7 (KCTD7) was named after the structural homology of its predicted N-terminal broad complex, tramtrack and bric à brac/poxvirus and zinc finger domain with the T1 domain of the Kv potassium channel, but its expression profile and cellular function are still largely unknown. We have recently reported a homozygous nonsense mutation of KCTD7 in patients with a novel form of autosomal recessive progressive myoclonic epilepsy. Here, we show that KCTD7 expression hyperpolarizes the cell membrane and reduces the excitability of transfected neurons in patch clamp experiments. We found the expression of KCTD7 in the hippocampal and Purkinje cells of the murine brain, an expression profile consistent with our patients' phenotype. The effect on the plasma membrane resting potential is possibly mediated by Cullin-3, as we demonstrated direct molecular interaction of KCTD7 with Cullin-3 in co-immunoprecipitation assays. Our data link progressive myoclonic epilepsy to an inherited defect of the neuron plasma membrane's resting potential in the brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710140     DOI: 10.1007/s12035-011-8194-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  27 in total

Review 1.  Controlling potassium channel activities: Interplay between the membrane and intracellular factors.

Authors:  B A Yi; D L Minor; Y F Lin; Y N Jan; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases.

Authors:  Yolanda Bayón; Antonio G Trinidad; María L de la Puerta; María Del Carmen Rodríguez; Jori Bogetz; Ana Rojas; José M De Pereda; Souad Rahmouni; Scott Williams; Shu-Ichi Matsuzawa; John C Reed; Mariano Sánchez Crespo; Tomas Mustelin; Andrés Alonso
Journal:  FEBS J       Date:  2008-06-28       Impact factor: 5.542

Review 3.  Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.

Authors:  Tateki Fujiwara
Journal:  Epilepsy Res       Date:  2006-06-27       Impact factor: 3.045

4.  Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway.

Authors:  Gregory D Salinas; Leslie A C Blair; Leigh A Needleman; Justina D Gonzales; Ying Chen; Min Li; Jeffrey D Singer; John Marshall
Journal:  J Biol Chem       Date:  2006-10-24       Impact factor: 5.157

Review 5.  Sodium channel SCN1A and epilepsy: mutations and mechanisms.

Authors:  Andrew Escayg; Alan L Goldin
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

6.  The kainate receptor subunit GluR6 mediates metabotropic regulation of the slow and medium AHP currents in mouse hippocampal neurones.

Authors:  André Fisahn; Stephen F Heinemann; Chris J McBain
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

7.  Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by ubiquitination. Novel role for Nedd4-2.

Authors:  Jenny Ekberg; Friderike Schuetz; Natasha A Boase; Sarah-Jane Conroy; Jantina Manning; Sharad Kumar; Philip Poronnik; David J Adams
Journal:  J Biol Chem       Date:  2007-02-23       Impact factor: 5.157

8.  Nedd4-2 functionally interacts with ClC-5: involvement in constitutive albumin endocytosis in proximal tubule cells.

Authors:  Deanne H Hryciw; Jenny Ekberg; Aven Lee; Ingrid L Lensink; Sharad Kumar; William B Guggino; David I Cook; Carol A Pollock; Philip Poronnik
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

9.  Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation.

Authors:  Gianluca Canettieri; Lucia Di Marcotullio; Azzura Greco; Sonia Coni; Laura Antonucci; Paola Infante; Laura Pietrosanti; Enrico De Smaele; Elisabetta Ferretti; Evelina Miele; Marianna Pelloni; Giuseppina De Simone; Emilia Maria Pedone; Paola Gallinari; Alessandra Giorgi; Christian Steinkühler; Luigi Vitagliano; Carlo Pedone; M Eugenià Schinin; Isabella Screpanti; Alberto Gulino
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

10.  Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination.

Authors:  Christoph Boehmer; Jörg Laufer; Sankarganesh Jeyaraj; Fabian Klaus; Ricco Lindner; Florian Lang; Monica Palmada
Journal:  Cell Physiol Biochem       Date:  2008-12-09
View more
  24 in total

1.  Progressive myoclonic epilepsy-associated gene Kctd7 regulates retinal neurovascular patterning and function.

Authors:  Jonathan Alevy; Courtney A Burger; Nicholas E Albrecht; Danye Jiang; Melanie A Samuel
Journal:  Neurochem Int       Date:  2019-06-06       Impact factor: 3.921

2.  Recombination mapping using Boolean logic and high-density SNP genotyping for exome sequence filtering.

Authors:  Thomas C Markello; Ted Han; Hannah Carlson-Donohoe; Chidi Ahaghotu; Ursula Harper; MaryPat Jones; Settara Chandrasekharappa; Yair Anikster; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Mol Genet Metab       Date:  2011-12-23       Impact factor: 4.797

3.  A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.

Authors:  John F Staropoli; Amel Karaa; Elaine T Lim; Andrew Kirby; Naser Elbalalesy; Stephen G Romansky; Karen B Leydiker; Scott H Coppel; Rosemary Barone; Winnie Xin; Marcy E MacDonald; Jose E Abdenur; Mark J Daly; Katherine B Sims; Susan L Cotman
Journal:  Am J Hum Genet       Date:  2012-06-28       Impact factor: 11.025

Review 4.  The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.

Authors:  Alessandro Orsini; Angelo Valetto; Veronica Bertini; Mariagrazia Esposito; Niccolò Carli; Berge A Minassian; Alice Bonuccelli; Diego Peroni; Roberto Michelucci; Pasquale Striano
Journal:  Seizure       Date:  2019-08-23       Impact factor: 3.184

5.  A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome.

Authors:  Lubov Blumkin; Sara Kivity; Dorit Lev; Sarit Cohen; Ruth Shomrat; Tally Lerman-Sagie; Esther Leshinsky-Silver
Journal:  J Neurol       Date:  2012-05-26       Impact factor: 4.849

6.  Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.

Authors:  Maria Kousi; Verneri Anttila; Angela Schulz; Stella Calafato; Eveliina Jakkula; Erik Riesch; Liisa Myllykangas; Hannu Kalimo; Meral Topçu; Sarenur Gökben; Fusun Alehan; Johannes R Lemke; Michael Alber; Aarno Palotie; Outi Kopra; Anna-Elina Lehesjoki
Journal:  J Med Genet       Date:  2012-06       Impact factor: 6.318

Review 7.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

Review 8.  The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications.

Authors:  Pascal Genschik; Izabela Sumara; Esther Lechner
Journal:  EMBO J       Date:  2013-08-02       Impact factor: 11.598

Review 9.  The molecular biology of genetic-based epilepsies.

Authors:  Hao Deng; Xiaofei Xiu; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

10.  KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect.

Authors:  Kyle A Metz; Xinchen Teng; Isabelle Coppens; Heather M Lamb; Bart E Wagner; Jill A Rosenfeld; Xianghui Chen; Yu Zhang; Hee Jong Kim; Michael E Meadow; Tim Sen Wang; Edda D Haberlandt; Glenn W Anderson; Esther Leshinsky-Silver; Weimin Bi; Thomas C Markello; Marsha Pratt; Nawal Makhseed; Adolfo Garnica; Noelle R Danylchuk; Thomas A Burrow; Parul Jayakar; Dianalee McKnight; Satish Agadi; Hatha Gbedawo; Christine Stanley; Michael Alber; Isabelle Prehl; Katrina Peariso; Min Tsui Ong; Santosh R Mordekar; Michael J Parker; Daniel Crooks; Pankaj B Agrawal; Gerard T Berry; Tobias Loddenkemper; Yaping Yang; Gustavo H B Maegawa; Abdel Aouacheria; Janet G Markle; James A Wohlschlegel; Adam L Hartman; J Marie Hardwick
Journal:  Ann Neurol       Date:  2018-11-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.